Enhanced FGF23 Serum Concentrations and Phosphaturia in Gene Targeted Mice Expressing WNK-Resistant Spak

By  

Kidney and Blood Pressure Research, Vol. 36, Iss. 1, 2012-12 ,pp. : 355-364

Karger

Access to resources Recommend Favorite

Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus

By  

American Journal of Nephrology, Vol. 42, Iss. 6, 2015-0 ,pp. : 391-401

Karger

Access to resources Recommend Favorite

Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency

By  

Nephron, Vol. 131, Iss. 3, 2015-0 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT)

By  

Nephron, Vol. 134, Iss. 4, 2016-07 ,pp. : 215-220

Karger

Access to resources Recommend Favorite

FGF23: A Mature Renal and Cardiovascular Risk Factor?

By  

Blood Purification, Vol. 36, Iss. 1, 2013-05 ,pp. : 52-57

Karger

Access to resources Recommend Favorite